SciTech Development
Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
Active
Multinational
United States
Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
HQUnited States
Confidence12